Domenico Incandela

Domenico Incandela

Auto-generated profile, based on publicly available information

Domenico Incandela

Obstetrics and Gynecology Unit, ARNAS Civico Di Cristina Benfratelli , Palermo

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
GAGiulia Alabiso
Giulia Alabiso
LALuigi Alio
Luigi Alio
SASaverio Arena
Saverio Arena
APAllegra Barbasetti di Prun
Allegra Barbasetti di Prun
VBValentino Bergamini
Valentino Bergamini
Errico ZupiErrico Zupi
Errico Zupi

29 November 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
AMAntonio Maiorana
Antonio Maiorana
MMMarianna Maranto
Marianna Maranto
Vincenzo RestivoVincenzo Restivo
Vincenzo Restivo
DGDaniele Lo Gerfo
Daniele Lo Gerfo
GMGabriella Minneci
Gabriella Minneci
DIDomenico Incandela
Domenico Incandela
Purpose: To evaluate the efficacy and long-term safety (up to 108 months) of treatment with Dienogest in patients with endometriosis. Methods: Patients with chronic pelvic pain endometriosis-related were enrolled in this observational study from June 2012 to July 2021. The patients enrolled took Dienogest 2 mg as a single daily administration. Group B of long-term therapy patients (over 15 months) were compared with group A of short-term therapy patients (0–15 months). The effects of the drug on pain variation were assessed using the VAS scale and endometriomas dimensions through ultrasonographic evaluation. Furthermore, has been valuated the appearance of side effects and the effect of the drug on bone metabolism by performing MOC every 24 months in group B. Results: 157 patients were enrolled. The mean size of the major endometrioma progressively decreased from 33.2 mm (29.4–36.9) at T0 to 7 mm (0–15.8) after 108 months of treatment. We found a significant improvement in dysmenorrhea, dyspareunia, dyschezia and non-cyclic pelvic pain. As for the side effects, both groups complained menstrual alterations present in 22.9%. In 27.6% of group B, osteopenia was found. Group B had a higher percentage statistically significant of side effects such as headaches, weight gain and libido reduction compared to group A. 2 Conclusion: Long-term therapy with Dienogest has proven effective in controlling the symptoms of the disease and reducing the size of endometriomas, with an increase in the positive effects related to the duration of the intake and in the absence of serious adverse events. Study approved by the "Palermo 2" Ethics Committee on July 2, 2012 No. 16.

4 February 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
Antonio MaioranaAntonio Maiorana
Antonio Maiorana
PAPietro Alfano
Pietro Alfano
AMAntonella Mercurio
Antonella Mercurio
SMSalvatore Marcantonio
Salvatore Marcantonio
GMGabriella Minneci
Gabriella Minneci
PAPalma Audino
Palma Audino
Purpose: The aims of this observational study were: to assess the relationship between psychological variables, pain, Duration Untreated Endometriosis (DUE) in a sample of women with Endometriosis; and to assess the effect of dienogest 2 mg/daily (DNG) and dienogest/ethinylestradiol 0.03 mg/daily (EE/DNG) on Symptoms, QoL, HRQoL, pain and sexual satisfaction, over time. Methods: 64 women constituted the study group; (56%) took DNG and (44%) took EE/DNG. VAS, SF-36, EHP-30 and ISS were used to assess endometriosis-associated pelvic pain, QoL, HRQoL and sexual satisfaction, respectively. The study included one follow-up at 18 months. Results: At T0, a longer period of DUE was related both to worst HRQoL and Physical QoL. At T1, a correlation was found between longer DUE and worst HRQoL. At T0, a negative correlation was found between VAS and PCS and between VAS and EHP-30. At T1, the same above correlation was found between VAS and PCS/MCS and VAS and EHP-30 scale. There was a correlation between ISS and VAS. ANOVA showed a reduction in dysmenorrhea, in general pain level and an improvement in emotional wellbeing, relationship with medical profession, and PCS over time, regardless to type of treatment. Moreover, a significant time × treatment group interaction for dysmenorrhea was found. Conclusion: DUE and pain are important variables related to psychological aspects of women with endometriosis. Treatment with both DNG and EE/DNG may have positive effects on the QoL, HRQoL and symptoms. Moreover, DNG seems to have a greater effect than EE/DNG on dyspareunia reduction over time.

22 May 2014 in Case Reports in Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
LGLaura Giambanco
Laura Giambanco
DIDomenico Incandela
Domenico Incandela
Antonio MaioranaAntonio Maiorana
Antonio Maiorana
WAWalter Alio
Walter Alio
LALuigi Alio
Luigi Alio
Introduction. Brugada syndrome is characterized by a disruption of heart’s normal rhythm. It is an autosomal dominant disease due to a mutation of SNC5A gene. Its prevalence is low all over the world, but it is a lethal disease. Sudden cardiac death is the result of phenotypic manifestation of Brugada syndrome. Among asymptomatic Brugada patients, arrhythmia could be provoked by physical activity, fever, or pregnancy. About obstetrical management, very few data or reports have been published since this syndrome has been diagnosed in late 1992.Case Presentation. A 20-year-old pregnant woman at 13 weeks of gestation was referred to our department because of her familial history of sudden cardiac deaths. Brothers and sisters of her mother died of Brugada syndrome in childhood or older and live components of this family were carrier of mutation in Brugada gene. The pregnancy was uneventful. The patient gave birth vaginally without any arrhythmia. Strictly cardiological monitoring was performed during labour, delivery, and 12 hours of the postpartum.Conclusion. Even though patient at low risk may never have arrhythmia, some conditions could represent a Brugada trigger. The management could be very easy and uneventful. Otherwise it could be very difficult with need of ECMO or antiarrhythmics drugs or intracardiac device. Obstetrical management of Brugada pregnant women should be very strict and multidisciplinary in cooperation with cardiologist and anaesthesiologist and should provide an informed consent to the couple.

1 January 2014 in Pan African Medical Journal
Verified
Journal Article
Open access
Antonio MaioranaAntonio Maiorana
Antonio Maiorana
DIDomenico Incandela
Domenico Incandela
LGLaura Giambanco
Laura Giambanco
WAWalter Alio
Walter Alio
LALuigi Alio
Luigi Alio
Pregnancy, the implantation of a fertilized ovum outside the endometrial cavity, occurs in 1.5%-2% of pregnancies. It is one of the major causes (about 6%) of maternal death during the first trimester of pregnancy. The remaining 5% implant in the ovary, peritoneal cavity, within the cervix, and the omental pregnancy is the least common form of abdominal pregnancies. A review of the literature on Medline for the period 1958-2012 reported only 16 cases of omental pregnancy. Here we report a case of primary omental pregnancy in a nulliparous woman. A 24 year-old woman gravid 1, para 0, with lower abdominal pain. Her last menstrual period occurred 8 weeks before the visit. The physical examination revealed abdominal tenderness in the lower quadrants, she was not bleeding. Transvaginal ultrasound showed: a free anechoic/hypoechoic area of 30 x 57 mm in the pouch of Douglas and the endometrium was homogeneus with a thickness of 12 mm and no evidence of gestational sac in the uterine cavity. Laboratory data revealed a normal cell blood count and beta hcg levels of 8047 IU / L. Because of continuing abdominal pain and a diagnosis of ectopic pregnancy a diagnostic laparoscopy was performed, which showed hemoperitoneum. Further inspection of abdominal cavity revealed a bloody lesion that was tenaciously adherent to the omentum, using non traumatic laparoscopic forceps and bipolar scissors we carefully removed a friable mass of about 30 mm from the omental attachments. Histological examination showed the presence of blood clot material mixed with trophoblastic tissue. Ultrasound evaluation and and hCG assessment are important to determine the extrauterine location of the ectopic pregnancy but the early diagnosis of abdominal pregnancy requires also a laparoscopic evaluation and, as our case has highlighted, thorough abdominal exploration especially in the absence of adnexal findings when ectopic pregnancy is highly suspected. Early diagnosis of omental pregnancy is difficult but essential to reduce the high mortality risk for the mother.

18 June 2012 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
APAntonino Perino
Antonino Perino
DMDonatella Mangione
Donatella Mangione
ASAlessandro Svelato
Alessandro Svelato
FFFrancesco Forlani
Francesco Forlani
FGFiorella Gargano
Fiorella Gargano
RVRenato Venezia
Renato Venezia
Click on the article title to read more.